Sort
48,018 grants matching “immunotherapy”
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Tumor and Host Immune signatures associated with health disparities in outcomes following GD2 immunotherapy in neuroblastoma
$576,659Kelly C Goldsmith · Emory University · R01 · FY2024 · CA
Role of sub-activation-threshold TCR interactions in maintaining T cell memory
$576,638Nevil John Singh · University Of Maryland Baltimore · R01 · FY2017 · AI
Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer
$576,611Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2021 · CA
Enhancing Innate and Adaptive Immunity to Improve Sepsis Survival
$576,604Richard Samuel Hotchkiss · Washington University · R35 · FY2023 · GM
Protein kinase C signaling in prostate cancer health disparities
$576,595Marcelo Gabriel Kazanietz · University Of Miami School Of Medicine · R01 · FY2024 · CA
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$576,552Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2018 · CA
Advancing the translatability of mouse models for cancer immunotherapy
$576,547Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2019 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$576,505Philip D Greenberg · University Of Washington · R01 · FY2016 · CA
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$576,453Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$576,453Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
ITIM-receptors for cancer treatment
$576,447Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2021 · CA
Investigational Cancer Therapeutics Training Program
$576,429Alexander Drilon · Sloan-Kettering Inst Can Research · T32 · FY2022 · CA
TREATMENT AND RELAPSE PREVENTION OF HEPATOCELLULAR CARCINOMA BY COMBINED CRYOABLATION-IMMUNOTHERAPY
$576,417University Of California, San Diego · · FY2020 · Department of the Army
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
$576,387Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Molecular Genetic Analysis of Mycobacterium tuberculosis
$576,342William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Molecular Genetic Analysis of Mycobacterium tuberculosis
$576,342William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · AI
The integrated mechanobiology and glycobiology of bone metastasis
$576,337Claudia Fischbach · Cornell University · R01 · FY2025 · CA
Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer
$576,314James S Duncan · Yale University · R01 · FY2023 · CA
Specific Adoptive Immunotherapy of Leukemia
$576,225Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2008 · CA
Single Cell Methods for Bioeffector Discovery and Analysis
$576,206Brian O Bachmann · Vanderbilt University · R01 · FY2023 · CA
Nortriptyline-mediated attenuation of alpha-synuclein pathology in Parkinson's disease
$576,131Timothy J. Collier · Michigan State University · R01 · FY2016 · NS
Tissue ProcessingSequencing Core
$576,068Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Project 1
$576,031David J Odde · University Of Minnesota · P01 · FY2021 · CA
Genetic Control of the SYK Tyrosine-protein Kinase in Allergy
$576,014Li Gao · Johns Hopkins University · R01 · FY2024 · AI